Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Giridhar Shivalingaiah

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Cold Spring Harbor Perspectives in Medicine|August 15, 2018
Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and InteractionsKlaus Scheffzek, Giridhar Shivalingaiah
Plos One|May 21, 2014
Development of a multipurpose GATEWAY-based lentiviral tetracycline-regulated conditional RNAi system (GLTR)Reinhard Sigl, Christian Ploner, Giridhar Shivalingaiah, et al.
British Journal of Cancer|August 17, 2018
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancerIrina Tsibulak, Verena Wieser, Christine Degasper, et al.
Oncotarget|May 1, 2018
<i>BRCA1/2</i> and <i>TP53</i> mutation status associates with <i>PD-1</i> and <i>PD-L1</i> expression in ovarian cancerVerena Wieser, Inge Gaugg, Martina Fleischer, et al.
Journal of Cancer|February 13, 2020
The miR-34 family and its clinical significance in ovarian cancerHannah Welponer, Irina Tsibulak, Verena Wieser, et al.
Science (New York, N.Y.)|September 23, 2017
Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signalingMariana E G de Araujo, Andreas Naschberger, Barbara G Fürnrohr, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Cold Spring Harbor Perspectives in Medicine|August 15, 2018
Ras-Specific GTPase-Activating Proteins-Structures, Mechanisms, and InteractionsKlaus Scheffzek, Giridhar Shivalingaiah
Plos One|May 21, 2014
Development of a multipurpose GATEWAY-based lentiviral tetracycline-regulated conditional RNAi system (GLTR)Reinhard Sigl, Christian Ploner, Giridhar Shivalingaiah, et al.
British Journal of Cancer|August 17, 2018
BRCA1 and BRCA2 mRNA-expression prove to be of clinical impact in ovarian cancerIrina Tsibulak, Verena Wieser, Christine Degasper, et al.
Oncotarget|May 1, 2018
<i>BRCA1/2</i> and <i>TP53</i> mutation status associates with <i>PD-1</i> and <i>PD-L1</i> expression in ovarian cancerVerena Wieser, Inge Gaugg, Martina Fleischer, et al.
Journal of Cancer|February 13, 2020
The miR-34 family and its clinical significance in ovarian cancerHannah Welponer, Irina Tsibulak, Verena Wieser, et al.
Science (New York, N.Y.)|September 23, 2017
Crystal structure of the human lysosomal mTORC1 scaffold complex and its impact on signalingMariana E G de Araujo, Andreas Naschberger, Barbara G Fürnrohr, et al.
Pageof 1